Medical Journals

Low Sensitivity of the Positron Emission Tomography Ligand [11c]diprenorphine to Agonist Opiates.

Authors:
  • Hume Susan P
  • Lingford-Hughes Anne R
  • Nataf Valerie
  • Hirani Ella
  • Ahmad Rabia
  • Davies Andrew N
  • Nutt David J

From: Hammersmith Imanet Ltd., Hammersmith Hospital, London, United Kingdom.

The Journal of pharmacology and experimental therapeutics

  • Publish Date: Aug 2007
  • ISSN: 0022-3565
  • Volume: 322
  • Issue: 2
  • Pages: 661-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Hume Susan P, Lingford-Hughes Anne R, Nataf Valerie, et al. Low Sensitivity of the Positron Emission Tomography Ligand [11c]diprenorphine to Agonist Opiates.. J. Pharmacol. Exp. Ther. Aug 2007;322:661-7

Abstract

Previously, we reported minimal opioid receptor occupancy following a clinical dose of the micro-opioid agonist, methadone, measured in vivo using positron emission tomography (PET) with [(11)C]diprenorphine and subsequently used rats to obtain experimental data in support of a high receptor reserve hypothesis (Melichar et al., 2005). Here, we report on further preclinical studies investigating opioid receptor occupancy with oxycodone (micro- and kappa-receptor agonist), morphine (micro-receptor agonist), and buprenorphine (partial agonist at the micro-receptor and antagonist at the delta- and kappa-receptors), each given at antinociceptive doses. In vivo binding of [(11)C]diprenorphine was not significantly reduced after treatment with the full agonists but was reduced by approximately 90% by buprenorphine. In addition, given that [(11)C]diprenorphine is a non-subtype-specific PET tracer, there was no regional variation that might feasibly be interpreted as due to differences in opioid subtype distribution. The data support minimal competition between the high-efficacy agonists and the non-subtype-selective antagonist radioligand and highlight the limitations of [(11)C]diprenorphine PET to monitor in vivo occupancy. Alternative means may be needed to address clinical issues regarding opioid receptor occupancy that are required to optimize treatment strategies.

Mesh Headings (Keywords): Analgesics, Opioid, Animals, Brain, Brain Stem, Buprenorphine, Carbon Radioisotopes, Cerebellum, Competitive Bidding, Diprenorphine, Limbic System, Male, Morphine, Oxycodone, Positron-Emission Tomography, Prosencephalon, Quinine, Rats, Rats, Sprague-Dawley, Receptors, Opioid, Reproducibility of Results, Tissue Distribution


Check for Full Text / PubMed Unique Identifier (PMID): 17488881


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.